These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24122383)

  • 21. Hemophagocytic syndrome in an adolescent with Crohn disease receiving azathioprine and infliximab.
    Francolla KA; Altman A; Sylvester FA
    J Pediatr Gastroenterol Nutr; 2008 Aug; 47(2):193-5. PubMed ID: 18664872
    [No Abstract]   [Full Text] [Related]  

  • 22. [Is there any interest to dose the azathioprine's metabolites during inflammatory bowel diseases?].
    Melaouhia S; Fékih M; Ferchichi H; Bouissorra H; Ben Mustapha N; Boubaker J; Filali A; Lakhal M; Klouz A
    Therapie; 2013; 68(5):313-20. PubMed ID: 24225042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colonic small cell neuroendocrine carcinoma in a patient with long-standing ulcerative colitis treated with azathioprine.
    Zerboni G; Capurso G; Pilozzi E; Papi C
    Dig Liver Dis; 2016 Jul; 48(7):822-3. PubMed ID: 27103360
    [No Abstract]   [Full Text] [Related]  

  • 24. Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease.
    Mottet C; Schoepfer AM; Juillerat P; Cosnes J; Froehlich F; Kessler-Brondolo V; Seibold F; Rogler G; Vavricka SR; Michetti P
    Inflamm Bowel Dis; 2016 Nov; 22(11):2733-2747. PubMed ID: 27760078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of Leiomyosarcoma in a Patient Treated with Azathioprine.
    Abdallah M; Saleh M; Elgouhari H; Huntington MK
    S D Med; 2019 May; 72(5):214-216. PubMed ID: 31454474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spot diagnosis: eruptive melanocytic naevi during azathioprine therapy in Crohn's disease.
    Wonders J; De Boer NK; Van Weyenberg SJ
    J Crohns Colitis; 2012 Jun; 6(5):636. PubMed ID: 22402255
    [No Abstract]   [Full Text] [Related]  

  • 27. Severe muscular weakness: an unusual adverse effect of azathioprine therapy.
    Karhadkar AS; Schwartz HJ; Arora M; Dutta SK
    J Clin Gastroenterol; 2006 Aug; 40(7):626-8. PubMed ID: 16917406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Azathioprine-induced hepatotoxicity in a patient with Crohn's disease].
    Ruiz-Clavijo D; Arín A; Vila JJ; Albéniz E; Picazo R; Casi M
    An Sist Sanit Navar; 2013 Sep; 36(2):353-6. PubMed ID: 24008542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunosuppressive drugs in intestinal diseases (author's transl)].
    Müller-Schoop J
    Ther Umsch; 1979 May; 36(5):439-42. PubMed ID: 36684
    [No Abstract]   [Full Text] [Related]  

  • 30. Recent advances using immunomodulators for inflammatory bowel disease.
    Nielsen OH; Bjerrum JT; Herfarth H; Rogler G
    J Clin Pharmacol; 2013 Jun; 53(6):575-88. PubMed ID: 23408468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ki-1 lymphoma of the skin in a patient with Crohn's disease undergoing treatment with azathioprine].
    Martínez Tirado P; Redondo Cerezo E; Gónzalez Aranda Y; J Cabello Tapia M; Nogueras López F; Gómez García M
    Gastroenterol Hepatol; 2001 May; 24(5):271-2. PubMed ID: 11412602
    [No Abstract]   [Full Text] [Related]  

  • 32. Steering azathioprine safely: lessons from pharmacogenetics.
    Aithal GP; Hoffman BJ
    Am J Gastroenterol; 2001 Nov; 96(11):3202-3. PubMed ID: 11721776
    [No Abstract]   [Full Text] [Related]  

  • 33. Immunosuppression in patients with Crohn's disease and neoplasia: an ongoing clinical dilemma.
    Dasari BV; McBrearty A; Gardiner K
    Dis Colon Rectum; 2012 Sep; 55(9):1008-11. PubMed ID: 22874610
    [No Abstract]   [Full Text] [Related]  

  • 34. Azathioprine therapy for inflammatory bowel disease. A preliminary report.
    Brown CH; Achkar E
    Am J Gastroenterol; 1970 Oct; 54(4):363-77. PubMed ID: 5478849
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment with immunosupressants in a patient with Crohn's disease and common variable immunodeficiency].
    Trigo Salado C; Leo Carnerero E; Pizarro Moreno Á; de la Cruz Ramírez MD; Araujo Miguez Á; Herrera Justiniano JM; Márquez Galán JL
    Gastroenterol Hepatol; 2015 Nov; 38(9):544-5. PubMed ID: 25454598
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunosuppressive therapy of ulcerative colitis and Crohn's disease].
    Reitzig P; Apostoloff E; Lisewski G; Spranger GD
    Dtsch Gesundheitsw; 1973; 28(5):238-40. PubMed ID: 4722981
    [No Abstract]   [Full Text] [Related]  

  • 37. Azathioprine hypersensitivity mimicking underlying inflammatory bowel disease.
    Corbett M; Schlup M
    Intern Med J; 2001 Aug; 31(6):366-7. PubMed ID: 11529592
    [No Abstract]   [Full Text] [Related]  

  • 38. Pure red cell aplasia due to azathioprine therapy for Crohn's disease.
    Kamath N; Pai CG; Deltombe T
    Indian J Pharmacol; 2016; 48(1):86-7. PubMed ID: 26997730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Pitfall to Avoid: Hyperlipasemia, Azathioprine, and Autoimmune Pancreatitis.
    Hernanz N; Lopez-Sanroman A
    J Crohns Colitis; 2017 Jan; 11(1):134. PubMed ID: 27385401
    [No Abstract]   [Full Text] [Related]  

  • 40. Visceral Leishmaniasis Infection in a Patient with Crohn's Disease Treated with Azathioprine.
    Valdés Delgado T; Cordero Ruiz P; Bellido Muñoz F
    J Crohns Colitis; 2017 Oct; 11(10):1282-1283. PubMed ID: 28967958
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.